SCHEMBL29536743

SCHEMBL29536743

Nc1cc(CC(=O)Nc2cccc(F)c2)[nH]n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ KDR P35968 3/20 0.49
▸ CSF1R P07333 2/20 0.49
▸ KIT P10721 2/20 0.49
▸ LCK P06239 2/20 0.49
▸ ABL1 P00519 1/20 0.49
▸ FYN P06241 1/20 0.49
▸ LYN P07948 1/20 0.49
▸ SRC P12931 1/20 0.49
▸ FLT1 P17948 1/20 0.49
▸ FLT4 P35916 1/20 0.49
▸ FLT3 P36888 1/20 0.49
▸ BLK P51451 1/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ ROCK2 O75116 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ AURKB Q96GD4 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3187182 1.00 MEN1 (0.56) MEN1KMT2AKDRCSF1RKIT
SCHEMBL23500689 0.87 GAA (0.54) MEN1KMT2AKDRKITFLT3
SCHEMBL19263436 0.85 KMT2A (0.56) MEN1KMT2ACSF1RFLT3SMN1; SMN2
SCHEMBL3188022 0.80 MEN1 (0.50) MEN1KMT2AKDRCSF1RKIT
SCHEMBL27983617 0.80 KMT2A (0.56) MEN1KMT2AKDRCSF1RKIT
SCHEMBL29536398 0.79 AKT1 (0.44) KDRFLT1FLT4FLT3RAB9A
Hydrochloric Acid SCHEMBL29536731 0.78 KMT2A (0.57) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL29536538 0.78 POLB (0.47) KMT2AKDRKITFLT3SMN1; SMN2
SCHEMBL23501077 0.78 POLB (0.47) KMT2AKDRKITFLT3SMN1; SMN2
SCHEMBL4291228 0.77 NPC1 (0.56) MEN1KMT2AKDRCSF1RKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112939948-B Novel quinazoline-containing compound, intermediate and application thereof 苏州美诺医药科技有限公司 2022-05-17 — — CN disclosed
Send feedback